Cross-Sectional and Longitudinal Analyses of the Association Between Statin Use and Age-Related Hearing Loss
Overall, the findings suggest statin benefits for mid-to-high frequency hearing for middle-aged to older adults at early stages of ARHL. On the basis of evidence suggesting that some statins have beneficial effects on hearing, well-controlled clinical trials are needed to examine effects of statin use and statin types on ARHL in the general population.
Authors
- Annie N. Simpson (ORCID: https://orcid.org/0000-0002-7216-1036)
- Lizmarie G. Maldonado (ORCID: https://orcid.org/0000-0002-4236-6225)
- Katharine Fernandez (ORCID: https://orcid.org/0000-0003-0522-388X)
- Lois J. Matthews (ORCID: https://orcid.org/0009-0008-7239-9918)
- Lisa L. Cunningham (ORCID: https://orcid.org/0000-0001-5320-964X)
- Judy R. Dubno (ORCID: https://orcid.org/0000-0003-2340-4721)
Institutions
- Medical University of South Carolina (US)
- National Institute on Deafness and Other Communication Disorders (US)
Publication Details
- Journal
- Drugs & Aging
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1007/s40266-025-01268-4
- Primary Topic
- Hearing, Cochlea, Tinnitus, Genetics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Medical University of South Carolina
- University of South Carolina
- National Institutes of Health
- South Carolina Clinical and Translational Research Institute, Medical University of South Carolina
- National Institute on Deafness and Other Communication Disorders
- National Center for Research Resources
- National Center for Advancing Translational Sciences
- NHLBI Division of Intramural Research